Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Rocket Pharmaceuticals stock
Learn how to easily invest in Rocket Pharmaceuticals stock.
Rocket Pharmaceuticals Inc is a biotechnology business based in the US. Rocket Pharmaceuticals shares (RCKT) are listed on the NASDAQ and all prices are listed in US Dollars. Rocket Pharmaceuticals employs 151 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Rocket Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – RCKT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Rocket Pharmaceuticals stock price (NASDAQ: RCKT)Use our graph to track the performance of RCKT stocks over time.
Rocket Pharmaceuticals shares at a glance
|Latest market close||$15.50|
|52-week range||$7.57 - $36.87|
|50-day moving average||$15.42|
|200-day moving average||$15.37|
|Wall St. target price||$54.80|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.69|
Buy Rocket Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Rocket Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Rocket Pharmaceuticals price performance over time
|1 week (2022-09-27)||14.99%|
|1 month (2022-09-02)||-0.26%|
|3 months (2022-07-01)||7.27%|
|6 months (2022-04-04)||-6.85%|
|1 year (2021-10-04)||-46.55%|
|2 years (2020-10-02)||-33.49%|
|3 years (2019-10-04)||33.05%|
|5 years (2017-10-04)||659.80%|
Rocket Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-24.59%|
|Return on equity TTM||-43.72%|
|Market capitalisation||$1.1 billion|
TTM: trailing 12 months
Rocket Pharmaceuticals share dividends
We're not expecting Rocket Pharmaceuticals to pay a dividend over the next 12 months.
Have Rocket Pharmaceuticals's shares ever split?
Rocket Pharmaceuticals's shares were split on a 1:4 basis on 4 January 2018. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Rocket Pharmaceuticals shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Rocket Pharmaceuticals shares which in turn could have impacted Rocket Pharmaceuticals's share price.
Rocket Pharmaceuticals share price volatility
Over the last 12 months, Rocket Pharmaceuticals's shares have ranged in value from as little as $7.565 up to $36.87. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Rocket Pharmaceuticals's is 1.346. This would suggest that Rocket Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Rocket Pharmaceuticals overview
Rocket Pharmaceuticals, Inc. , together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; CIEMAT and UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey.
Rocket Pharmaceuticals in the news
Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial for RP-A501 in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022
Frequently asked questionsWhat percentage of Rocket Pharmaceuticals is owned by insiders or institutions?
Currently 4.386% of Rocket Pharmaceuticals shares are held by insiders and 101.228% by institutions. How many people work for Rocket Pharmaceuticals?
Latest data suggests 151 work at Rocket Pharmaceuticals. When does the fiscal year end for Rocket Pharmaceuticals?
Rocket Pharmaceuticals's fiscal year ends in December. Where is Rocket Pharmaceuticals based?
Rocket Pharmaceuticals's address is: 9 Cedarbrook Drive, Cranbury, NJ, United States, 08512 What is Rocket Pharmaceuticals's ISIN number?
Rocket Pharmaceuticals's international securities identification number is: US77313F1066 What is Rocket Pharmaceuticals's CUSIP number?
Rocket Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 45780V102
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert